2601 - 2625 of 7730 Results
Title
Year
- Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons2021RESTRICTEDTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 23
- Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein2021RESTRICTEDTitle: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synucleinJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429263Citation Count: 9
- Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”2021RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
-
RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial2021RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xBest OA location URL: https://discovery.ucl.ac.uk/10134438/1/Dam%20%20%20%20PASSPORT%20Primary%20MS%20rev%20NMED-A110517A%20Final%20PIPE-18442%20w%20Figs.pdfCitation Count: 67
-
RESTRICTEDTitle: Telemedicine and Deep brain stimulation - Current practices and recommendationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.001Citation Count: 19
-
RESTRICTEDTitle: Uremic Striatopallidal Syndrome Manifesting as Acute Onset ChoreaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13285Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13285Citation Count: 2
-
RESTRICTEDTitle: Use of Figurative Language by People With Parkinson Disease to Describe “Off” PeriodsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/cpj.0000000000001059Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/4/e462.full.pdfCitation Count: 2
- Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis2021RESTRICTEDTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: http://manuscript.elsevier.com/S1389945721003361/pdf/S1389945721003361.pdfCitation Count: 4
- Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)2021RESTRICTEDTitle: Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)Journal Name: American Journal of Medical Genetics Part APublisher: WileyVol: 185Issue #: 12Start Page: 3717End Page: 3727Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ajmg.a.62437Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717864Citation Count: 5
- Directed Brain Connectivity Identifies Widespread Functional Network Abnormalities in Parkinson’s Disease2021RESTRICTEDTitle: Directed Brain Connectivity Identifies Widespread Functional Network Abnormalities in Parkinson’s DiseaseJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 32Issue #: 3Start Page: 593End Page: 607Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/cercor/bhab237Best OA location URL: https://academic.oup.com/cercor/article-pdf/32/3/593/42259699/bhab237.pdfCitation Count: 7
-
RESTRICTEDTitle: Emerging hiPSC Models for Drug Discovery in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 15Start Page: 8196End Page: 8196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22158196Best OA location URL: https://www.mdpi.com/1422-0067/22/15/8196/pdf?version=1627640850Citation Count: 11
- From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease2021RESTRICTEDTitle: From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 14Start Page: 2945End Page: 2951Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20210383Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/14/2945/918073/bcj-2021-0383.pdfCitation Count: 3
- Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change2021RESTRICTEDTitle: Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of ChangeJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2853End Page: 2861Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28730Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688189Citation Count: 8
- A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s disease2021RESTRICTEDTitle: A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 7Start Page: e0254834End Page: e0254834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0254834Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0254834&type=printableCitation Count: 8
-
RESTRICTEDTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408600Citation Count: 18
-
RESTRICTEDTitle: They Look but Do Not See—Gaze‐Evoked Eyelid SpasmJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1123End Page: 1125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13279Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13279Citation Count: 0
-
RESTRICTEDTitle: A Multi‐center Genome‐wide Association Study of Cervical DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2795End Page: 2801Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28732Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688173Citation Count: 6
- Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS)2021RESTRICTEDTitle: Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS)Journal Name: Journal of Medical GeneticsPublisher: BMJVol: 59Issue #: 7Start Page: 706End Page: 709Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jmedgenet-2021-107758Citation Count: 5
-
RESTRICTEDTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990146Citation Count: 34
- Advanced Machine Learning Tools to Monitor Biomarkers of Dysphagia: A Wearable Sensor Proof-of-Concept Study2021RESTRICTEDTitle: Advanced Machine Learning Tools to Monitor Biomarkers of Dysphagia: A Wearable Sensor Proof-of-Concept StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 5Issue #: 2Start Page: 167End Page: 175Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000517144Best OA location URL: https://www.karger.com/Article/Pdf/517144Citation Count: 17
- Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice2021RESTRICTEDTitle: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in miceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-24567-xBest OA location URL: https://www.nature.com/articles/s41467-021-24567-x.pdfCitation Count: 8
- Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration2021RESTRICTEDTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486338Citation Count: 14
-
RESTRICTEDTitle: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 399End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02349-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02349-5.pdfCitation Count: 13
-
RESTRICTEDTitle: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00203-9Best OA location URL: https://www.nature.com/articles/s41531-021-00203-9.pdfCitation Count: 83